Mankind Pharma will acquire Panacea’s formulations


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Mankind Pharma is set to acquire Panacea Biotec Pharma’s formulations for an estimated Rs 1872 crores.

Mankind Pharma is set to acquire Panacea Biotec Pharma’s formulations for an estimated Rs 1872 crores. Mankind Pharma will be able to use Panacea’s formulations in India and Nepal markets. With this acquisition, Mankind Pharma will be able to explore and integrate novel therapeutic areas like lifestyle, oncology and transplant business.

An update claims that the shared of Panacea Biotec zoomed by 5% to Rs 198.50. Before it was Rs 197.10. Panacea has created a niche in the chronic and transplant business and their products are inherently backed up with thorough R&D and are supported by highly complex and distinctive technology. They hold the right to manufacture the Sputnik V Covid-19 vaccine.

Panacea Biotec Pharma is a subsidy of Panacea Biotec. The Serum Institute of India owned 8.59% stakes in this. In December 2021, sold 358,000 of its equity shares on NSE at Rs 278.15. Beleaguered Panacea Biotec was noticeably struggling to repay its debt of Rs 750 crore to Piramal Enterprises and India Resurgence Fund or IndiaRF.

Tags : #MankindPharma #PanaceaBiotecPharma #pharmacy #formulations #acquisitions #healthacqusition #alert #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026